Literature DB >> 20676247

The iron chancellor and the fabian.

Robert G Evans.   

Abstract

Adam Wagstaff (2009) reports on a statistical comparison of social health insurance (SHI) versus tax financed (TF) health systems within the OECD. On average, SHI financing is more expensive than TF and yields no better health outcomes. It lowers overall labour force participation and reduces the share of the formal sector. Why, then, is interest in SHI increasing in developing countries?Consider the historical origins for SHI and TF. Bismarck (SHI) was a Prussian aristocrat; Beveridge (TF) was a socialist. TF is inherently egalitarian; SHI adapts readily to the preservation of inequality and privilege in both financing and access to care. This may be the real attraction of SHI in countries with highly unequal income distributions.

Entities:  

Year:  2009        PMID: 20676247      PMCID: PMC2732651     

Source DB:  PubMed          Journal:  Healthc Policy        ISSN: 1715-6572


  3 in total

1.  Equity in the finance of health care: some further international comparisons.

Authors:  A Wagstaff; E van Doorslaer; H van der Burg; S Calonge; T Christiansen; G Citoni; U G Gerdtham; M Gerfin; L Gross; U Häkinnen; P Johnson; J John; J Klavus; C Lachaud; J Lauritsen; R Leu; B Nolan; E Perán; J Pereira; C Propper; F Puffer; L Rochaix; M Rodríguez; M Schellhorn; O Winkelhake
Journal:  J Health Econ       Date:  1999-06       Impact factor: 3.883

2.  More doctors or better care?

Authors:  Diane E Watson; Kimberlyn M McGrail
Journal:  Healthc Policy       Date:  2009-08

3.  Measuring the health of nations: updating an earlier analysis.

Authors:  Ellen Nolte; C Martin McKee
Journal:  Health Aff (Millwood)       Date:  2008 Jan-Feb       Impact factor: 6.301

  3 in total
  1 in total

1.  Becoming a general practitioner--which factors have most impact on career choice of medical students?

Authors:  Kathrin Kiolbassa; Antje Miksch; Katja Hermann; Andreas Loh; Joachim Szecsenyi; Stefanie Joos; Katja Goetz
Journal:  BMC Fam Pract       Date:  2011-05-09       Impact factor: 2.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.